Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

Amy Giles
Increasing Engagement

Thomas Shea
Programmatic Marketing

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

David Linetsky
Patient Activation

Mike Viscel
Increasing Engagement

Anil Bhaskar
Unified Customer Experience

Suma Ramadas, PhD
Medical Affairs

Frank X. Powers
Healthcare Challenger Brands

Laura Blair
Medication Adherence

Daniel Sontupe
Market Access